tislelizumab-jsgr

tislelizumab-jsgr (TEVIMBRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.

TEVIMBRA is a marketed brand name for tislelizumab-jsgr. Check FDA Drugs@FDA for the current US label holder and prescribing information.

tislelizumab-jsgr has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.